Picture of Phathom Pharmaceuticals logo

PHAT — Phathom Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Phathom Pharmaceuticals Submits Citizen Petition To FDA

Dec 11 (Reuters) - Phathom Pharmaceuticals  PHAT.O :
    * PHATHOM PHARMACEUTICALS SUBMITS CITIZEN PETITION TO FDA
SEEKING
CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA® (VONOPRAZAN)
TABLETS
    * PHATHOM: PETITION REQUESTS CORRECTION OF ORANGE BOOK
LISTINGS
FOR VOQUEZNA 10 MG,20 MG TABLETS TO ACCURATELY REFLECT 10-YEAR
NCE EXCLUSIVITY PERIOD
    * PHATHOM PHARMACEUTICALS INC: EXCLUSIVITY PERIOD IS UNTIL
MAY 3,
2032

Source text:  ID:nGNXMt0NF 
Further company coverage:  PHAT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Phathom Pharmaceuticals

See all news